Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumio Kodama

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer|September 5, 2002
Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphomaNaoto Tomita, Fumio Kodama, Heiwa Kanamori, et al.
International Journal of Hematology|August 24, 2006
Secondary central nervous system lymphomaNaoto Tomita, Fumio Kodama, Heiwa Kanamori, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 14, 2004
[Clinical significance of detecting strong bcl-2 protein expression with flow cytometry in follicular lymphoma]Shoichi Kobayashi, Shigeki Motomura, Yoko Kishi, et al.
Internal Medicine (Tokyo, Japan)|April 6, 2006
Prognostic factors in diffuse large B-cell lymphoma treated by risk-adopted therapyNaoto Tomita, Fumio Kodama, Shigeki Motomura, et al.
Leukemia & Lymphoma|August 15, 2003
Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphomaNaoto Tomita, Fumio Kodama, Maki Takabayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 30, 2004
[Fatal acute visceral disseminated varicella-zoster virus infection in a patient with chronic graft-versus-host disease]Etsuko Yamazaki, Aki Kamijoh, Jun Taguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 2006
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients]Shigeki Motomura, Chizuko Hashimoto, Fumio Kodama, et al.
Medical Oncology (Northwood, London, England)|June 24, 2008
Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in JapanAtsuko Fujita, Naoto Tomita, Hiroyuki Fujita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2002
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events]Fumio Kodama, Hiroshi Mohri, Shigeki Motomura, et al.
Leukemia & Lymphoma|July 15, 2006
Phase II study of CHOP-GR therapy for advanced-stage follicular lymphomaNaoto Tomita, Fumio Kodama, Rika Oshima, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer|September 5, 2002
Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphomaNaoto Tomita, Fumio Kodama, Heiwa Kanamori, et al.
International Journal of Hematology|August 24, 2006
Secondary central nervous system lymphomaNaoto Tomita, Fumio Kodama, Heiwa Kanamori, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 14, 2004
[Clinical significance of detecting strong bcl-2 protein expression with flow cytometry in follicular lymphoma]Shoichi Kobayashi, Shigeki Motomura, Yoko Kishi, et al.
Internal Medicine (Tokyo, Japan)|April 6, 2006
Prognostic factors in diffuse large B-cell lymphoma treated by risk-adopted therapyNaoto Tomita, Fumio Kodama, Shigeki Motomura, et al.
Leukemia & Lymphoma|August 15, 2003
Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphomaNaoto Tomita, Fumio Kodama, Maki Takabayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 30, 2004
[Fatal acute visceral disseminated varicella-zoster virus infection in a patient with chronic graft-versus-host disease]Etsuko Yamazaki, Aki Kamijoh, Jun Taguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 2006
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients]Shigeki Motomura, Chizuko Hashimoto, Fumio Kodama, et al.
Medical Oncology (Northwood, London, England)|June 24, 2008
Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in JapanAtsuko Fujita, Naoto Tomita, Hiroyuki Fujita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2002
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events]Fumio Kodama, Hiroshi Mohri, Shigeki Motomura, et al.
Leukemia & Lymphoma|July 15, 2006
Phase II study of CHOP-GR therapy for advanced-stage follicular lymphomaNaoto Tomita, Fumio Kodama, Rika Oshima, et al.
Pageof 2